An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

NCT01666691 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Beloranib
DRUG: Placebo

Sponsor

Zafgen, Inc.